Tradestie Institutional Equity Comparison Engine

AGEN vs XOMA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AGEN Overall Edge

AGEN Captures Institutional Edge (4โ€“0 Pillars ยท 3โ€“7 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Agenus Inc. (AGEN) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, AGEN trades at 3.7x Forward P/E with 38.9% operating margin (+4.1% YoY revenue) versus XOMA at 21.5x Forward P/E and -3.9% operating margin (-22.6% YoY). In options structure, AGEN sits in BREAKDOWN (11th %ile IV; Dealer Gamma Walls on Pro) against XOMA sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner AGEN
AGEN 3.7x vs XOMA 21.5x Fwd P/E
Growth & Margin Winner AGEN
Op Margin 38.9% vs -3.9% ยท YoY +4.1% vs -22.6%
Momentum & Technical Winner AGEN
1Y +46.4% vs +44.0% ยท 52W Pos 48% vs 78%
Options & Structure Winner AGEN
BREAKDOWN (11th %ile IV) vs UNCLASSIFIED (100th %ile IV)
AGEN NASDAQ
Agenus Inc.
Biological Products, (No Disgnostic Substances)
$6.34
-5.79% 1D
Market Cap $310.8M
1M Return +4.97%
1Y Return +46.42%
Forward P/E 3.7x
Unified AI Score
52.7 / 100 HOLD
Tech 44.0 Fund 55.0 Flow 66.0 Mom 50.0
XOMA NASDAQ
XOMA Royalty Corporation Common Stock
Pharmaceutical Preparations
$40.17
-9.16% 1D
Market Cap $781.8M
1M Return -3.81%
1Y Return +43.98%
Forward P/E 21.5x
Unified AI Score
55.8 / 100 HOLD
Tech 40.0 Fund 52.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AGEN +46.42% XOMA +43.98% Spread: +16.74 pp (AGEN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AGEN TTM Op. Margin: 38.9% XOMA TTM Op. Margin: -3.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AGEN vs XOMA. Trailing 12-month operating profitability (AGEN 38.9% vs XOMA -3.9%) and valuation multiples (AGEN 3.7x vs XOMA 21.5x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AGEN (3) vs XOMA (7)
Institutional Metric AGEN XOMA Criterion Row Winner
Market Capitalization Scale $310.8M $781.8M Larger Scale XOMA
Trailing P/E Ratio Valuation 29.9x 28.2x Lower Multiple XOMA
Forward P/E Ratio Valuation 3.7x 21.5x Lower Multiple AGEN
Revenue Growth (YoY) Growth +4.1% -22.6% Higher Growth AGEN
Operating Margin (TTM) Profitability 38.9% -3.9% Higher Margin AGEN
Net Profit Margin Profitability 30.8% 69.6% Higher Margin XOMA
Return on Equity (ROE) Capital Efficiency -1278.8% 34.2% Higher ROE XOMA
52-Week Range Position Momentum 48% ($3โ€“$10) 78% ($22โ€“$45) Stronger Trend XOMA
Beta / 30D Volatility Risk Regime 1.60ฮฒ ยท 76% Vol 0.68ฮฒ ยท 37% Vol Lower Realized Risk XOMA
Unified Institutional Score Composite Signal 52.7 / 100 (HOLD) 55.8 / 100 (HOLD) Higher Composite XOMA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AGEN vs XOMA Buy Guide
AGEN BREAKDOWN
33d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 11th %ile
IV Regime Compressed (<25th %ile)
Live AGEN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
XOMA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live XOMA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AGEN nor XOMA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.